"Scientists at the University of Wisconsin Carbone Cancer Center (UWCCC) report that a new class of tumor-targeting agents can seek out and find dozens of solid tumors, even illuminating brain cancer stem cells that resist current treatments.
"What's more, years of animal studies and early human clinical trials show that this tumor-targeting, alkylphosphocholine (APC) molecule can deliver two types of 'payloads' directly to cancer cells: a radioactive or fluorescent imaging label, or a radioactive medicine that binds and kills cancer cells.
"The results are reported in today's issue of the journal Science Translational Medicine, and featured in the journal's cover illustration and podcast."
Editor's note: This story discusses a new method to make cancer cells visible to oncologists, and to deliver drugs directly to cells. The method uses a molecule called APC, which makes a beeline for cancer cells and can deliver imaging labels or radiotherapy treatments.